Radioiodine in Low-Risk Thyroid Cancer | NEJM
1 Vues
• 07/06/23
0
0
Intégrer
administrator
Les abonnés
Radioiodine is typically administered after thyroidectomy in patients with thyroid cancer, but its benefits in those with low-risk disease are controversial. New research findings are summarized in a short video.
To see the full article, follow this link: https://nej.md/3HvClQD
Montre plus
Commentaires de Facebook
SORT BY-
Meilleures Commentaires
-
Derniers Commentaires